全EXOME定序市場規模、佔有率和成長分析（按產品、技術、工作流程、應用、最終用途和地區）- 產業預測 2025-2032

預計 2023 年全球全EXOME定序市場規模將達到 4.9688 億美元，並將從 2024 年的 5.8334 億美元成長至 2032 年的 21.0506 億美元，預測期內複合年成長率為 1.4%（ 2025-2032年），預計複合年成長率為17.4%。

整個EXOME定序市場正在經歷強勁成長，這得益於促進早期和準確檢測遺傳和慢性疾病的技術進步。研究和診斷領域的新應用加上成本的下降，大大推動了個人化醫療解決方案的需求。醫療保健專業人員現在正在使用全外EXOME定序來識別基因突變、為個別患者提供個人化治療並改善臨床結果。華大基因與中國醫療服務提供者的合作，凸顯了這些服務的可近性日益提高。值得注意的是，Natera 獲得 FDA 認可的突破性設備 Signatera 等創新技術彰顯了EXOME定序在癌症診斷和監測方面的變革潛力。隨著個人化醫療的普及，市場將隨著新診斷方法和新技術的出現而不斷擴大。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全EXOME定序市場規模（依產品）

• 市場概況
• 裝置
• 耗材
• 系統
• 套件
• 服務

全EXOME定序市場規模（依技術）

• 市場概況
• 合成定序
• 離子半導體序列
• 其他

全EXOME定序市場規模（依工作流程）

• 市場概況
• 前序
• 順序
• 資料分析

全EXOME定序市場規模（依應用）

• 市場概況
• 臨床診斷
• 藥物研發
• 個人化醫療
• 農業和動物研究
• 其他

全EXOME定序市場規模（依最終用途）

• 市場概況
• 學術研究所
• 醫院和診所
• 製藥和生物技術公司
• 其他

全EXOME定序市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Pacific Biosciences of California, Inc.（PacBio）（USA）
• Oxford Nanopore Technologies plc.（UK）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（USA）
• Novogene Co., Ltd.（China）
• Azenta, Inc.（formerly GENEWIZ）（USA）
• CD Genomics（USA）
• Psomagen, Inc.（South Korea）
• F. Hoffmann-La Roche AG（Switzerland）
• 10x Genomics, Inc.（USA）
• Bionano Genomics, Inc.（USA）
• Dante Labs（Italy）
• MGI Tech Co., Ltd.（China）
• GeneDx Holdings Corp.（USA）
• Helix OpCo, LLC（USA）

結論和建議

Global Whole Exome Sequencing Market size was valued at USD 496.88 million in 2023 and is poised to grow from USD 583.34 million in 2024 to USD 2105.06 million by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The market for whole exome sequencing is experiencing robust growth driven by advancements in technology that facilitate early and accurate detection of genetic and chronic diseases. New applications in research and diagnostics, coupled with decreasing costs, have significantly increased demand for personalized medical solutions. Medical professionals now leverage whole exome sequencing to identify genetic variations and tailor treatments to individual patients, enhancing clinical outcomes. Collaborations, such as the partnership between a Chinese healthcare provider and BGI Genomics, underscore the rising accessibility of these services. Notably, innovations like Natera's FDA-designated breakthrough device, Signatera, exemplify the transformative potential of exome sequencing in cancer diagnosis and monitoring. As personalized medicine gains traction, the market is poised for continued expansion with emerging diagnostics and technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segmental Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A key factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans that align with the patient's specific genetic profile and risk of disease. This bespoke approach not only enhances the efficacy of therapies but also promotes better patient outcomes. The continued advancements in sequencing technologies and data analysis capabilities have made whole exome sequencing increasingly accessible and cost-effective, thus encouraging its implementation in clinical environments. As the emphasis on personalized healthcare continues to grow, so does the demand for whole exome sequencing, shaping the future landscape of medical treatment.

Restraints in the Global Whole Exome Sequencing Market

A notable constraint impacting the global whole exome sequencing market is the challenges tied to data complexity and interpretation. The considerable volume of genomic data produced presents significant difficulties in analysis, necessitating extensive expertise and time. Ensuring that the results are both accurate and reliable is essential for making sound medical decisions. The reliance on advanced bioinformatics tools and qualified personnel for effective data handling and interpretation limits the broader adoption of whole exome sequencing. Consequently, this factor restricts its accessibility and feasibility in various healthcare environments, hindering the implementation of this innovative technology.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is witnessing a significant trend driven by the integration of artificial intelligence (AI) and machine learning (ML) algorithms into data analysis and interpretation processes. This innovative approach is transforming how vast amounts of genomic data generated through whole exome sequencing are processed, enabling more efficient identification of genetic variations and disease associations. By automating data handling, AI and ML improve accuracy and efficiency in genomic analysis, thus facilitating faster, precise diagnoses and personalized treatment strategies. As these technologies continue to evolve, they are set to revolutionize genomic medicine, underscoring their critical role in shaping the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• System
• Kits
• Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Agriculture and Animal Research
• Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic And Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global Whole Exome Sequencing Market Size & CAGR (2025-2032)

• North America (Product, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Workflow, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (PacBio) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc. (formerly GENEWIZ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dante Labs (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI Tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx Holdings Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helix OpCo, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations